FRAMINGHAM, MA-Genzyme Corp. plans to develop a 300,000-sf manufacturing plant here next to the company's existing campus, which already includes manufacturing facilities, research and development ...

FRAMINGHAM — Sanofi Genzyme is doubling ... With some 5,000 workers in Massachusetts, Sanofi Genzyme continues to be the state’s largest employer in the life sciences industry.

Genzyme (GENZ) says it will double the size of its newest Massachusetts manufacturing facility in Framingham, Massachusetts to nearly 2 million square feet over the next ten years, expanding on a ...

Biotechnology researcher Genzyme ... resources in Massachusetts. Another protein-manufacturing site is slated for construction in Waltham, Mass., the company said. In Framingham, Architectural ...

Genzyme's manufacturing improvements continue to pay off, allowing it to return to the market with a full supply of its thyroid cancer treatment, Thyrogen. The drug is being manufactured at ...

Genzyme Corp.'s current facility in Framingham. The inclusion of $ ... taken by the state in January in the form of a $250,000 Massachusetts Opportunity Relocation and Expansion (MORE) grant.

The company said Genzyme's new manufacturing plant in Framingham, MA, won approval from European regulators to produce Fabrazyme—which means Fabry disease patients will soon be on their way to ...

The company is the largest biomedical employer in the area with 2,000 employees in Central Massachusetts. Genzyme moved approximately 500 employees to the Westborough location from Framingham in 2014.

Framingham is where Genzyme last year opened a $330 million manufacturing plant, in part using a $14.3 million grant from the state-created Massachusetts Life Sciences Center – the quasi-public ...

BOSTON (Reuters) - Genzyme Corp , which is fending off a hostile bid from French drugmaker Sanofi-Aventis SA , said third-quarter earnings quadrupled as it increased shipments of its biggest ...